9
Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J. Dement Geriatr Cogn Disord 2004; 18: 227-232

Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Embed Size (px)

Citation preview

Page 1: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Specific functional effects of

memantine treatment in patients with

moderate to severe Alzheimer’s

disease

Doody R., Wirth Y., Schmitt F. and Möbius H.J.

Dement Geriatr Cogn Disord 2004; 18: 227-232

Page 2: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Baseline Characteristics

Doody et al., Dement Geriatr Cogn Disord 2004

US Study EU Study

Patients completing study, n (%) 97 (77%) 84 (67%) 39 (95%) 37 (97%)

Gender, femalen (%) 91 (72%) 79 (63%) 29 (71%) 24 (63%)

Mean age (years) 75.9 76.3 73.4 74.9

Race, Caucasiann (%) 112 (89%) 115 (91%) 41 (100%) 38 (100%)

Mean MMSEscore at baseline 7.7 8.1 6.7 6.8

Memantine Placebo Memantine Placebo(N = 126) (N = 126) (N = 41) (N = 38)

Residential status outpatients nursing home patients

Page 3: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

* p < 0.05, # p < 0.10

Beneficial Effects of Memantine on Function in AD Outpatients (I)

Mean change (±SEM) from baseline in ADCS-ADL19 item scores (US trial)

Improvement

-0.6 -0.4 -0.2 0 0.2-0.8

Worsening

0.4

Get around outside of his/her home

Dispose of garbage or litter

Find his/her personal belongings

Clear dishes from table after meal

Pay attention to conversation

Watch television

Use a telephone

Memantine

Placebo

#

*

*

*

#

Doody et al., Dement Geriatr Cogn Disord 2004

Page 4: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Mean change (±SEM) from baseline in ADCS-ADL19 item scores

Improvement

-0.6 -0.4 -0.2 0 0.2-0.8

Worsening

0.4

Turn light off without help

Turn light on without help

Turn off faucet without help

Run water from a faucet to wash

Obtain a hot or cold beverage

Left on his/her own

Memantine

Placebo

Beneficial Effects of Memantine on Function in AD Outpatients (II)

Doody et al., Dement Geriatr Cogn Disord 2004

Page 5: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Mean change (±SEM) from baseline in ADCS-ADL19 item scores (US trial)

Improvement

-0.6 -0.4 -0.2 0 0.2-0.8

Worsening

0.4

Physically getting dressed

Grooming

Bathing

Toiletting

Walking

Eating

Memantine

Placebo

Beneficial Effects of Memantine on Function in AD Outpatients (III)

Doody et al., Dement Geriatr Cogn Disord 2004

Page 6: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Mean change (±SEM) from baseline in ADCS-ADL19 item scores

Improvement

-0.6 -0.4 -0.2 0 0.2-0.8

Worsening

0.4

* p < 0.05, # p < 0.10

Pay attention to conversationTurn light off

Dispose of garbageTurn faucet off

Get around outsideUse a telephone

Run water from a faucet Walking

Watch televisionClear dishes from table

Find personal belongingsTurn light on

ToilettingEating

GroomingLeft on his/her own

BathingObtain a beverage

Getting dressed

*

*

*

#

#

Memantine

Placebo

Consistent Beneficial Effects on Function in AD Outpatients

Doody et al., Dement Geriatr Cogn Disord 2004

Page 7: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

* p < 0.05

Mean change (±SEM) from baseline in G2-scale scores (EU study)

Improvement

Mobility in bed

Ability to stand up

Ability to move

Ability to wash

Ability to bath/take a shower

Ability to dress

Ability to eat

Ability to drink

Use of toilet

0 -0.2 -0.4 -0.6 -0.8 Memantine

Placebo

0.2

*

*

*

*

*

*

Beneficial Effects of Memantine on Function in Nursing Home Patients (I)

Doody et al., Dement Geriatr Cogn Disord 2004

Page 8: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

# p < 0.10

Mean change (±SEM) from baseline in G2-scale scores(EU study)

Improvement

Understanding

Communicates

Orientation

Recognition of persons

Group activities

Hobbies

Sleeping-waking rhythm

Behaviour

0 -0.2 -0.4 -0.6 -0.8 Memantine

Placebo

0.2

#

#

Beneficial Effects of Memantine on Function in Nursing Home Patients (II)

Doody et al., Dement Geriatr Cogn Disord 2004

Page 9: Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer’s disease Doody R., Wirth Y., Schmitt F. and Möbius H.J

Summary

The ADL single item analyses consistently confirm that

memantine monotherapy provides significant benefits

on functional abilities for patients with moderate to

severe Alzheimer’s disease.

The benefits have been demonstrated in both

outpatients (Reisberg et al., 2003) and nursing home

patients (Winblad and Poritis, 1999).

The positive effects of memantine on function may not

only have a positive impact on the patient but also on

the caregiver and healthcare resource utilization.